A new international laboratory focused on the meeting point of artificial intelligence and metabolism has been formally launched to advance understanding of health across the human lifespan.
“The lab will bring together leading researchers from the CNRS and Imperial to advance our understanding of metabolism, from the molecular to whole organism level, with the potential to transform how we approach human health and disease. The lab is also a demonstration of how international scientific collaboration can shape important discussions with policymakers and provide a direct pathway to impact.” Professor Hugh Brady, President of Imperial, said.
He said the new facility aims to transform how human health and disease are approached. The International Research Laboratory in Multiscale Metabolism ‘Antoine Lavoisier’ was established through a partnership between Imperial College and France’s National Centre for Scientific Research (CNRS).
The lab plans to use artificial intelligence (AI), machine learning, and multiscale biology to analyze how metabolism functions in people, from the subcellular level to large populations Imperial and France’s CNRS celebrate launch of joint laboratory.
The research initiative is designed to improve health outcomes for people affected by obesity, diabetes, cardiometabolic diseases, associated cancers, and neurodegenerative conditions such as Alzheimer’s Disease or Parkinson’s Disease Imperial and France’s CNRS celebrate launch of joint laboratory.
Metabolic health defines female reproductive function
Polycystic Ovary Syndrome (PCOS) has been reclassified by the medical community as Polyendocrine Metabolic Ovarian Syndrome (PMOS). The growing importance of metabolic biology in health lies behind the change Metabolism at the centre of female reproductive health.
The renaming followed a global consensus process involving clinicians and patient advocates. It recognizes that reproductive function is fundamentally entwined with energy balance, nutrient sensing, and cardiometabolic health Metabolism at the centre of female reproductive health.
The new name reflects the condition’s complex endocrine and metabolic roots, moving beyond a narrow focus on ovarian morphology Metabolism at the centre of female reproductive health.
In related research, studies have demonstrated that metabolic hormones are key regulators of female physiology. Some research has identified a vicious cycle of metabolic and epigenetic reprogramming in granulosa cells. That cycle contributes to enhanced androgen synthesis in mouse models of PMOS Metabolism at the centre of female reproductive health.
CNRS and Imperial build on a record of joint research
The Antoine Lavoisier Laboratory will address conditions like diabetes, obesity, and neurodegenerative diseases. It will do so by combining clinical data, machine learning, and experimental biology across the UK and France Imperial and France’s CNRS celebrate launch of joint laboratory.
Professor Thierry Dauxois, Chairman and CEO of the CNRS, said that international collaboration is central to the CNRS-Imperial International Research Centre for Transformational Science and Technology. Imperial and the CNRS launched that centre in 2022 Imperial and France’s CNRS celebrate launch of joint laboratory.
The partnership emphasizes translational science. Therapies developed for obesity and diabetes may carry significant implications for managing PMOS and improving overall metabolic outcomes Metabolism at the centre of female reproductive health.
The CNRS is Imperial’s top European collaborator. The two bodies have published close to 3,000 joint papers in the last five years Imperial and France’s CNRS celebrate launch of joint laboratory.
The CNRS, France’s state research organisation, is the largest public research body in Europe and the second largest research organisation in the world. In 2020 it employed over 32,000 staff, including more than 16,000 tenured researchers, and it works through joint research units run in association with universities and other institutions.
It already has offices and research units across the globe, from Brussels and Beijing to Santiago de Chile and New Delhi, making the new laboratory a natural extension of its international reach.
To support early career researchers, Sandrine Heutz, Imperial’s Scientific Director of the CNRS-Imperial International Research Centre (IRC), and Dr Emmanuel Brouillet, CNRS Scientific Director of the CNRS-Imperial IRC, announced a new Marie Skłodowska-Curie Actions (MSCA) COFUND grant Imperial and France’s CNRS celebrate launch of joint laboratory.